S&P 500   3,953.31 (+0.49%)
DOW   33,764.04 (+0.49%)
QQQ   283.57 (+1.08%)
AAPL   142.61 (+1.18%)
MSFT   246.85 (+1.01%)
META   115.12 (+1.04%)
GOOGL   93.63 (-1.38%)
AMZN   89.78 (+1.49%)
TSLA   171.19 (-1.64%)
NVDA   167.77 (+4.08%)
NIO   13.21 (+5.01%)
BABA   92.99 (+5.28%)
AMD   70.45 (+0.44%)
T   19.25 (-0.26%)
MU   55.37 (+2.88%)
CGC   3.16 (-2.47%)
F   13.18 (+0.61%)
GE   84.42 (-0.68%)
DIS   92.51 (+0.39%)
AMC   6.22 (+2.81%)
PYPL   75.29 (+1.17%)
PFE   50.79 (+1.09%)
NFLX   308.59 (+0.06%)
S&P 500   3,953.31 (+0.49%)
DOW   33,764.04 (+0.49%)
QQQ   283.57 (+1.08%)
AAPL   142.61 (+1.18%)
MSFT   246.85 (+1.01%)
META   115.12 (+1.04%)
GOOGL   93.63 (-1.38%)
AMZN   89.78 (+1.49%)
TSLA   171.19 (-1.64%)
NVDA   167.77 (+4.08%)
NIO   13.21 (+5.01%)
BABA   92.99 (+5.28%)
AMD   70.45 (+0.44%)
T   19.25 (-0.26%)
MU   55.37 (+2.88%)
CGC   3.16 (-2.47%)
F   13.18 (+0.61%)
GE   84.42 (-0.68%)
DIS   92.51 (+0.39%)
AMC   6.22 (+2.81%)
PYPL   75.29 (+1.17%)
PFE   50.79 (+1.09%)
NFLX   308.59 (+0.06%)
S&P 500   3,953.31 (+0.49%)
DOW   33,764.04 (+0.49%)
QQQ   283.57 (+1.08%)
AAPL   142.61 (+1.18%)
MSFT   246.85 (+1.01%)
META   115.12 (+1.04%)
GOOGL   93.63 (-1.38%)
AMZN   89.78 (+1.49%)
TSLA   171.19 (-1.64%)
NVDA   167.77 (+4.08%)
NIO   13.21 (+5.01%)
BABA   92.99 (+5.28%)
AMD   70.45 (+0.44%)
T   19.25 (-0.26%)
MU   55.37 (+2.88%)
CGC   3.16 (-2.47%)
F   13.18 (+0.61%)
GE   84.42 (-0.68%)
DIS   92.51 (+0.39%)
AMC   6.22 (+2.81%)
PYPL   75.29 (+1.17%)
PFE   50.79 (+1.09%)
NFLX   308.59 (+0.06%)
S&P 500   3,953.31 (+0.49%)
DOW   33,764.04 (+0.49%)
QQQ   283.57 (+1.08%)
AAPL   142.61 (+1.18%)
MSFT   246.85 (+1.01%)
META   115.12 (+1.04%)
GOOGL   93.63 (-1.38%)
AMZN   89.78 (+1.49%)
TSLA   171.19 (-1.64%)
NVDA   167.77 (+4.08%)
NIO   13.21 (+5.01%)
BABA   92.99 (+5.28%)
AMD   70.45 (+0.44%)
T   19.25 (-0.26%)
MU   55.37 (+2.88%)
CGC   3.16 (-2.47%)
F   13.18 (+0.61%)
GE   84.42 (-0.68%)
DIS   92.51 (+0.39%)
AMC   6.22 (+2.81%)
PYPL   75.29 (+1.17%)
PFE   50.79 (+1.09%)
NFLX   308.59 (+0.06%)
NASDAQ:RCM

R1 RCM - RCM Stock Forecast, Price & News

$10.19
+0.33 (+3.35%)
(As of 12/8/2022 11:11 AM ET)
Add
Compare
Today's Range
$9.85
$10.30
50-Day Range
$6.90
$19.29
52-Week Range
$6.71
$27.86
Volume
39,026 shs
Average Volume
7.33 million shs
Market Capitalization
$4.24 billion
P/E Ratio
169.83
Dividend Yield
N/A
Price Target
$18.27

R1 RCM MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.90 Rating Score
Upside/​Downside
78.7% Upside
$17.62 Price Target
Short Interest
Bearish
7.89% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.33
Upright™ Environmental Score
News Sentiment
0.48mentions of R1 RCM in the last 14 days
Based on 16 Articles This Week
Insider Trading
Selling Shares
$306.45 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.06) to $0.33 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.79 out of 5 stars

Business Services Sector

33rd out of 320 stocks

Management Services Industry

1st out of 7 stocks

RCM stock logo

About R1 RCM (NASDAQ:RCM) Stock

R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company also provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. In addition, the company offers software-as-a-service based scheduling and patient access solutions. The company was founded in 2003 and is headquartered in Murray, Utah.

Receive RCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for R1 RCM and its competitors with MarketBeat's FREE daily newsletter.

RCM Stock News Headlines

R1 RCM (NASDAQ:RCM) Shares Gap Down to $10.11
R1 RCM (NASDAQ:RCM) Now Covered by Morgan Stanley
China Has Stunning Lithium Chokehold On U.S.
What's happening now is dangerous. The U.S. barely has any lithium so desperately needed for our military's equipment. China controls 80% of the world's lithium. If the communist country decides to withhold it from the U.S., our military could be brought to its knees.
What 9 Analyst Ratings Have To Say About R1 RCM
9 Analysts Have This to Say About R1 RCM
KeyCorp Raises R1 RCM (NASDAQ:RCM) Price Target to $15.00
China Has Stunning Lithium Chokehold On U.S.
What's happening now is dangerous. The U.S. barely has any lithium so desperately needed for our military's equipment. China controls 80% of the world's lithium. If the communist country decides to withhold it from the U.S., our military could be brought to its knees.
Why Shares of R1 RCM rose 10% on Tuesday
Brokerages Set R1 RCM Inc. (NASDAQ:RCM) Price Target at $18.67
5 Analysts Have This to Say About R1 RCM
Expert Ratings for R1 RCM
R1 RCM Shares Drop After Swing to 3Q Loss
R1 RCM Inc. (RCM) Q3 2022 Earnings Call Transcript
Why Is R1 RCM Stock Down 40% Today?
R1 RCM Inc.: R1 RCM Reports Third Quarter 2022 Results
R1 RCM Reports Third Quarter 2022 Results
R1 RCM Announces Leadership Succession Plan
See More Headlines
Receive RCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for R1 RCM and its competitors with MarketBeat's FREE daily newsletter.

RCM Company Calendar

Last Earnings
11/08/2022
Today
12/08/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/16/2023

Industry, Sector and Symbol

Industry
Management services
Sub-Industry
Health Care Services
Current Symbol
NASDAQ:RCM
CUSIP
00438V10
Employees
22,000
Year Founded
2003

Price Target and Rating

Average Stock Price Forecast
$17.62
High Stock Price Forecast
$32.00
Low Stock Price Forecast
$10.00
Forecasted Upside/Downside
+79.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.90
Research Coverage
11 Analysts

Profitability

Net Income
$97.20 million
Pretax Margin
1.02%

Debt

Sales & Book Value

Annual Sales
$1.47 billion
Cash Flow
$0.67 per share
Book Value
$1.25 per share

Miscellaneous

Free Float
169,103,000
Market Cap
$4.24 billion
Optionable
Not Optionable
Beta
0.79

Social Links


Key Executives

  • Mr. Joseph Gerard FlanaganMr. Joseph Gerard Flanagan (Age 51)
    CEO & Director
    Comp: $2.65M
  • Ms. Rachel Wilson (Age 49)
    Exec. VP, CFO & Treasurer
    Comp: $1.47M
  • Mr. John M. SparbyMr. John M. Sparby (Age 46)
    Exec. VP of Operations & Delivery and COO
    Comp: $1.01M
  • Mr. Gary S. Long (Age 51)
    Exec. VP & Chief Commercial Officer
    Comp: $911.83k
  • Mr. Lee Rivas
    Pres
  • Mr. Richard B. Evans Jr.Mr. Richard B. Evans Jr. (Age 54)
    Sr. VP, Corp. Controller & Chief Accounting Officer
  • Mr. Jay Sreedharan
    Chief Technology & Digital Officer
  • Mr. Atif A. Rahim
    Sr. VP of Investor Relations & Bus. Devel.
  • Mr. Corey Perman
    Exec. VP of Compliance & Risk
  • Mr. Sean Radcliffe
    Exec. VP, Gen. Counsel & Corp. Sec.













RCM Stock - Frequently Asked Questions

Should I buy or sell R1 RCM stock right now?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for R1 RCM in the last year. There are currently 1 hold rating and 10 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" RCM shares.
View RCM analyst ratings
or view top-rated stocks.

What is R1 RCM's stock price forecast for 2023?

11 Wall Street research analysts have issued 1-year price targets for R1 RCM's stock. Their RCM share price forecasts range from $10.00 to $32.00. On average, they predict the company's stock price to reach $17.62 in the next twelve months. This suggests a possible upside of 78.7% from the stock's current price.
View analysts price targets for RCM
or view top-rated stocks among Wall Street analysts.

How have RCM shares performed in 2022?

R1 RCM's stock was trading at $25.49 at the beginning of 2022. Since then, RCM shares have decreased by 61.3% and is now trading at $9.86.
View the best growth stocks for 2022 here
.

When is R1 RCM's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 16th 2023.
View our RCM earnings forecast
.

How were R1 RCM's earnings last quarter?

R1 RCM Inc. (NASDAQ:RCM) announced its earnings results on Tuesday, November, 8th. The healthcare provider reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.11 by $0.18. The healthcare provider earned $496 million during the quarter, compared to analyst estimates of $522.29 million. R1 RCM had a trailing twelve-month return on equity of 4.77% and a net margin of 0.93%.

What guidance has R1 RCM issued on next quarter's earnings?

R1 RCM updated its FY 2022 earnings guidance on Thursday, December, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.79 billion-$1.80 billion, compared to the consensus revenue estimate of $1.87 billion.

What is Joseph Flanagan's approval rating as R1 RCM's CEO?

253 employees have rated R1 RCM Chief Executive Officer Joseph Flanagan on Glassdoor.com. Joseph Flanagan has an approval rating of 70% among the company's employees.

What other stocks do shareholders of R1 RCM own?

Based on aggregate information from My MarketBeat watchlists, some companies that other R1 RCM investors own include NVIDIA (NVDA), JD.com (JD), Baozun (BZUN), Inseego (INSG), BioXcel Therapeutics (BTAI), Marvell Technology (MRVL), Akoustis Technologies (AKTS), Alibaba Group (BABA), Bilibili (BILI) and Model N (MODN).

What is R1 RCM's stock symbol?

R1 RCM trades on the NASDAQ under the ticker symbol "RCM."

Who are R1 RCM's major shareholders?

R1 RCM's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (3.99%), Vanguard Group Inc. (3.36%), Alliancebernstein L.P. (2.45%), State Street Corp (1.07%), Bank of New York Mellon Corp (0.99%) and Paradigm Capital Management Inc. NY (0.80%). Insiders that own company stock include Achi Series Lllp Tcp-Asc, Albert Rene Zimmerli, Alex Mandl, Gary Steven Long, John M Sparby, Joseph Gerard Flanagan, Michael C Feiner and Richard B Jr Evans.
View institutional ownership trends
.

How do I buy shares of R1 RCM?

Shares of RCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is R1 RCM's stock price today?

One share of RCM stock can currently be purchased for approximately $9.86.

How much money does R1 RCM make?

R1 RCM (NASDAQ:RCM) has a market capitalization of $4.11 billion and generates $1.47 billion in revenue each year. The healthcare provider earns $97.20 million in net income (profit) each year or $0.06 on an earnings per share basis.

How many employees does R1 RCM have?

The company employs 22,000 workers across the globe.

Does R1 RCM have any subsidiaries?
The following companies are subsidiares of R1 RCM: Accretive Health Mauritius Inc., Cerner RevWorks, Clearsight Intermediate Holdings Inc., Cloudmed, Flare Capital Partners Investment Company, Intermedix, Intermedix ARM LLC, Intermedix Corporation, Intermedix Holdings Inc., Intermedix Lietuva UAB, Intermedix Midco Inc., Intermedix Office Based LLC, Intermedix Staffing Inc., Medical Consultants Inc., Practice Support Resources LLC, Project Links Parent Inc., Project Roadrunner Merger Sub Inc., Project Roadrunner Parent Inc., R1 RCM Global Private Limited, R1 RCM India Private Limited, Rover16 Inc., SCHEDULING.COM INC., SCI Solutions, Tonic Health LLC, VisitPay, cGate Health Inc., and iVinci Partners LLC.
Read More
How can I contact R1 RCM?

R1 RCM's mailing address is 401 NORTH MICHIGAN AVENUE SUITE 2700, CHICAGO IL, 60611. The official website for the company is www.r1rcm.com. The healthcare provider can be reached via phone at (312) 324-7820, via email at arahim@r1rcm.com, or via fax at 302-655-5049.

This page (NASDAQ:RCM) was last updated on 12/8/2022 by MarketBeat.com Staff